Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.630
-0.110 (-6.32%)
At close: Jul 11, 2025, 4:00 PM
1.640
+0.010 (0.61%)
After-hours: Jul 11, 2025, 4:46 PM EDT

Caribou Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
151144507383908-
Upgrade
Market Cap Growth
-81.71%-71.59%32.27%-57.82%--
Upgrade
Enterprise Value
-29-11013768473-
Upgrade
Last Close Price
1.741.595.736.2815.09-
Upgrade
PS Ratio
15.9914.4114.7027.6694.63-
Upgrade
PB Ratio
0.740.571.381.272.34-
Upgrade
P/TBV Ratio
0.730.571.381.272.34-
Upgrade
EV/Sales Ratio
--3.994.9449.28-
Upgrade
Debt / Equity Ratio
0.120.110.070.09-0.09
Upgrade
Asset Turnover
0.030.030.090.030.040.25
Upgrade
Quick Ratio
7.416.9411.768.9714.871.70
Upgrade
Current Ratio
7.637.1611.979.2515.151.96
Upgrade
Return on Equity (ROE)
-52.76%-47.99%-30.50%-28.87%-32.99%-102.92%
Upgrade
Return on Assets (ROA)
-29.21%-27.18%-18.00%-16.30%-17.50%-46.09%
Upgrade
Return on Capital (ROIC)
-32.38%-30.02%-20.03%-18.56%-20.55%-65.87%
Upgrade
Earnings Yield
-93.80%-103.56%-20.14%-25.95%-7.37%-
Upgrade
FCF Yield
-90.20%-99.38%-20.70%-25.43%-3.81%-
Upgrade
Buyback Yield / Dilution
-12.77%-22.37%-21.39%-92.02%-270.47%-2.05%
Upgrade
Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q